The approval comes days after the NIH announcement of preliminary results showing a four-day shortening of hospital stays after treatment with the drug.
of the drug. In an experiment on 1,063 patients, the study found that while the drug did not statistically reduce mortality in COVID-19 patients, it did lead to median hospital stays of 11 days, rather than 15 for patients who received a placebo.on Friday with the CEO of Gilead Sciences, the drug's maker. Remdesivir is an anti-viral drug that interferes with the reproduction of viruses in cells, originally intended to treat the MERS and SARS coronaviruses.
"I think this really illustrates what can happen in such a short time," said Deborah Birx of the White House Coronavirus Task Force.of remdesivir in 237 patients published in The Lancet on Wednesday found no clinical benefits to treating COVID-19 patients with the drug, and was halted because it caused a higher percentage of side effects. However, the study did show similar signs of shortening hospital stays, although not to a statistically significant extent.
"The bottom line is that we have shown that an anti-viral can affect this virus and that is in and of itself a great advance," University of Toronto professor Peter Jüni, the editor-in-chief of the journal Trials, told BuzzFeed News. Jüni suggested that larger clinical trials with more patients will show when during an infection patients will benefit the most from infusion with the drug.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Could Remdesivir Be the First FDA-Approved Treatment for the Coronavirus?Dr. Fauci and President Trump hope so, based on an NIAID study released Wednesday, though there are reasons to restrain optimism.
Read more »
A ventilator developed by NASA has been approved by the FDA for coronavirus patientsA high-pressure ventilator prototype developed by NASA engineers to help coronavirus patients was approved by the Food and Drug Administration on Thursday, according to NASA.
Read more »
US FDA may announce emergency use of Gilead's coronavirus drugExperimental drug has proved effective against the new coronavirus in a major study, shortening the time it takes for patients to recover by four days on average, US government and company officials say.
Read more »
FDA Issues Emergency Approval For Coronavirus Treatment DrugBREAKING: The Food and Drug Administration has approved the experimental drug remdesivir for treating coronavirus patients.
Read more »
FDA Issues Emergency Approval For Coronavirus Treatment DrugBREAKING: The Food and Drug Administration has approved the experimental drug remdesivir for treating coronavirus patients.
Read more »